Morgens Waterfall Vintiadis & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,000	Closed	-$1.08M	–	22
2025 Q1	$1.08M	Buy	+4,000	New	+$1.08M	1.22%	16